🎓📹🎤 Le média #Chek a pris l’avis des #jeunes sur la RTS, qui assure chaque année la #formation de 50 stagiaires, dont Selma et Salomé. J’y explique que l’initiative du 8 mars menace la relève romande.

Instagram:
▶️ www.instagram.com/reel/DVRNYjY...

TikTok:
▶️ vm.tiktok.com/ZNRakGFC2/

MultiSearch Tag Explorer MultiSearch Tag Explorer - Explore tags and search results by aéPiot

Increase Your Website’s SEO Performance with Free Backlinks from aéPiot
#LOUGHBOROUGH #GRAMMAR #SCHOOL
multi-search-tag-explorer.aepiot.com/advanced-sea...
#CHEK DT
headlines-world.com/advanced-sea...

headlines-world.com

MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company MBody AI (NASDAQ: CHEK) said Check-Cap shareholders approved merger-related proposals with over 98% of votes, accelerating the company's transformation into a hardware-agnostic embodied AI provider. The merger is expected to close in the coming weeks, subject to customary closing conditions. MBody AI will operate the MBody AI Orchestrator platform to coordinate robots and sensors across hospitality, healthcare, logistics, retail, and data centers.

#CHEK MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company

www.stocktitan.net/news/CHEK/m-body-ai-chek...

MBody AI ($CHEK) Expands Global Leadership in Embodied AI With Major Wins MBody AI (NASDAQ: CHEK) announced major enterprise deployments, multi-year, multi-million-dollar contracts, and growing investor interest ahead of a merger vote on November 14, 2025 that would combine Check-Cap with MBody AI.The release highlights the MBody AI Orchestrator as a hardware-agnostic platform deployed at Fortune 500 clients, citing up to 40% labor reduction, 80% uptime improvement, and accelerating global adoption with "hundreds of millions" in investor interest.

#CHEK MBody AI ($CHEK) Expands Global Leadership in Embodied AI With Major Wins

www.stocktitan.net/news/CHEK/m-body-ai-chek...

#CBC
#CTV
#CHEK
#DavidEby

🚀 Exciting times for #CHEK! The merger with MBody AI is driving massive interest and trading activity. Despite overbought RSI, the MACD shows strong upward momentum. Consider a LONG position at $2.45, targeting $2.70 & $2.90. Stay alert for rapid moves! 📈 #StockMarket #TechStocks

Top after-hours breakouts in momentum stocks for Friday, September 12, 2025 sorted by range are $IHT $3.04 (52%), $CMCT $8.58 (8%), $CHEK $2.27 (204%), $GNLN $4 (6%) #CHEK #chartanalysis #smallcaps #daytrading

$40 Trillion Market Opportunity: Check-Cap Merges with MBody AI to Transform Autonomous Workforce Technology Check-Cap enters definitive merger with MBody AI to focus on embodied AI for autonomous workforce. Deal gives MBody AI 90% ownership, targets $40T market by 2050. Closing expected post-October shareholder vote.

#CHEK MBody AI and Check-Cap Enter into Definitive Merger Agreement

www.stocktitan.net/news/CHEK/m-body-ai-and-...

That's unfortunate. He's much too biased to be an influence on any actual journalist but I don't know if the press gallery has any so that's open. It was CHEK letting him act as a non-partisan that set ruined their news for me.
#bcpoli #Robshaw #CHEK

Check-Cap Claims BMO Executive Launched Coordinated Attack to Manipulate Stock During Israel Crisis Israeli medical diagnostics firm alleges BMO's Chris Taves spread false information to harm stock price. See legal implications and market impact details.

#CHEK Check-Cap claims BMO’s Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime

www.stocktitan.net/news/CHEK/check-cap-clai...

MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders MediPharm Labs Corp. (TSX: LABS) has filed proxy materials for its June 16, 2025 Annual and Special Meeting, facing a proxy battle with dissident shareholder Apollo Technology Capital Corp. The company reported strong 2024 performance with 27% year-over-year revenue growth and improved gross margins of 31% (up from 18% in 2023). The company's Adjusted EBITDA loss narrowed by $8.3M to $1.9M in 2024. Under CEO David Pidduck's leadership since 2022, MediPharm has transformed through strategic initiatives, including the successful VIVO Cannabis acquisition which doubled revenue and provided international market access. The company faces opposition from Apollo, which owns 3% of shares and is nominating six alternative board members. MediPharm's board raises concerns about Apollo's nominees, particularly regarding chairman Regan McGee's controversial business history and lack of industry experience.

#CHEK MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders

www.stocktitan.net/news/CHEK/medi-pharm-lab...

I gotta say…I’ve been incredibly disappointed and let down by CHEK News over the last few years but now…not even a PEEP from them on this? Huge local event that is global? What a fail by #CHEK #todsnanaimoinfusion

I just heard #Poillieve complain that #Canadians might start #HuntingandFishing on #PublicLands. #WTF
Poillievre plans to take away #HuntingRights from #Canadians??
#CBC
#CHEK
#Global
🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦

Always yield to parade floats! Join us for the 42nd Peninsula Co-op Santa Light Parade presented by @cheknews.ca at 5:30! @stacy-ross.bsky.social, Tess Van Straaten and I will be live with our full team on #CHEK, CHEK+ & the CHEK YouTube page #SantaClausParade #YYJ

passar vergonha na macumba #chek